TR202008828A2 - METHOD OF OBTAINING HIPPOPHAE RHAMNOIDES EXTRACT ENCAPSULATED WITH LIPOSOMAL TECHNOLOGY FOR USE IN COSMETIC FORMULAS - Google Patents
METHOD OF OBTAINING HIPPOPHAE RHAMNOIDES EXTRACT ENCAPSULATED WITH LIPOSOMAL TECHNOLOGY FOR USE IN COSMETIC FORMULASInfo
- Publication number
- TR202008828A2 TR202008828A2 TR2020/08828A TR202008828A TR202008828A2 TR 202008828 A2 TR202008828 A2 TR 202008828A2 TR 2020/08828 A TR2020/08828 A TR 2020/08828A TR 202008828 A TR202008828 A TR 202008828A TR 202008828 A2 TR202008828 A2 TR 202008828A2
- Authority
- TR
- Turkey
- Prior art keywords
- wild
- extract
- encapsulated
- personal care
- obtaining
- Prior art date
Links
- 239000000284 extract Substances 0.000 title claims abstract description 35
- 238000005516 engineering process Methods 0.000 title claims abstract description 20
- 240000000950 Hippophae rhamnoides Species 0.000 title claims abstract description 17
- 235000003145 Hippophae rhamnoides Nutrition 0.000 title claims abstract description 17
- 238000000034 method Methods 0.000 title claims description 22
- 239000002537 cosmetic Substances 0.000 title claims description 20
- 239000000203 mixture Substances 0.000 claims abstract description 32
- 238000004519 manufacturing process Methods 0.000 claims abstract description 11
- 239000002502 liposome Substances 0.000 claims description 26
- 239000000839 emulsion Substances 0.000 claims description 23
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 17
- 239000000787 lecithin Substances 0.000 claims description 10
- 229940067606 lecithin Drugs 0.000 claims description 10
- 235000010445 lecithin Nutrition 0.000 claims description 10
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 claims description 9
- 239000004615 ingredient Substances 0.000 claims description 9
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 claims description 8
- 238000002156 mixing Methods 0.000 claims description 8
- 230000015572 biosynthetic process Effects 0.000 claims description 7
- 239000011521 glass Substances 0.000 claims description 6
- 238000000605 extraction Methods 0.000 claims description 5
- 241000219100 Rhamnaceae Species 0.000 claims description 4
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 claims description 3
- 235000021314 Palmitic acid Nutrition 0.000 claims description 3
- 230000003712 anti-aging effect Effects 0.000 claims description 3
- 238000004090 dissolution Methods 0.000 claims description 3
- 238000010438 heat treatment Methods 0.000 claims description 3
- 229940042585 tocopherol acetate Drugs 0.000 claims description 3
- 150000003626 triacylglycerols Chemical class 0.000 claims description 3
- 238000001816 cooling Methods 0.000 claims description 2
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 claims description 2
- WWZKQHOCKIZLMA-UHFFFAOYSA-N octanoic acid Chemical compound CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 claims description 2
- 240000004670 Glycyrrhiza echinata Species 0.000 claims 3
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 claims 3
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 claims 3
- 235000004294 Ononis spinosa Nutrition 0.000 claims 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims 3
- 241000272875 Ardeidae Species 0.000 claims 1
- 244000146462 Centella asiatica Species 0.000 claims 1
- 235000004032 Centella asiatica Nutrition 0.000 claims 1
- 238000005303 weighing Methods 0.000 claims 1
- 238000009472 formulation Methods 0.000 abstract description 14
- 150000003904 phospholipids Chemical class 0.000 abstract description 14
- 229960004488 linolenic acid Drugs 0.000 abstract description 9
- 235000021122 unsaturated fatty acids Nutrition 0.000 abstract description 7
- 150000004670 unsaturated fatty acids Chemical class 0.000 abstract description 7
- 230000001172 regenerating effect Effects 0.000 abstract description 5
- 239000005642 Oleic acid Substances 0.000 abstract description 4
- 230000008439 repair process Effects 0.000 abstract description 4
- 235000021354 omega 7 monounsaturated fatty acids Nutrition 0.000 abstract description 3
- 230000036560 skin regeneration Effects 0.000 abstract description 2
- 210000003491 skin Anatomy 0.000 description 39
- 239000003921 oil Substances 0.000 description 36
- 235000019198 oils Nutrition 0.000 description 36
- 239000000047 product Substances 0.000 description 21
- 239000012071 phase Substances 0.000 description 20
- 239000002253 acid Substances 0.000 description 18
- 210000004027 cell Anatomy 0.000 description 15
- 241000196324 Embryophyta Species 0.000 description 12
- 235000013399 edible fruits Nutrition 0.000 description 12
- 238000005538 encapsulation Methods 0.000 description 12
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 description 11
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 description 11
- 235000020778 linoleic acid Nutrition 0.000 description 11
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 description 11
- 150000002632 lipids Chemical class 0.000 description 11
- 239000000126 substance Substances 0.000 description 11
- 150000007513 acids Chemical class 0.000 description 10
- 235000014113 dietary fatty acids Nutrition 0.000 description 10
- 229930195729 fatty acid Natural products 0.000 description 10
- 239000000194 fatty acid Substances 0.000 description 10
- 150000004665 fatty acids Chemical class 0.000 description 10
- 235000015112 vegetable and seed oil Nutrition 0.000 description 10
- 235000020661 alpha-linolenic acid Nutrition 0.000 description 9
- 239000006071 cream Substances 0.000 description 9
- 210000002615 epidermis Anatomy 0.000 description 9
- 239000010410 layer Substances 0.000 description 9
- 239000008158 vegetable oil Substances 0.000 description 9
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 8
- 230000000694 effects Effects 0.000 description 8
- 239000010699 lard oil Substances 0.000 description 8
- 238000011282 treatment Methods 0.000 description 8
- 241000229143 Hippophae Species 0.000 description 7
- 235000003935 Hippophae Nutrition 0.000 description 7
- 230000004888 barrier function Effects 0.000 description 7
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 6
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 6
- 239000012528 membrane Substances 0.000 description 6
- 210000004209 hair Anatomy 0.000 description 5
- 235000003441 saturated fatty acids Nutrition 0.000 description 5
- 150000004671 saturated fatty acids Chemical class 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- 230000036572 transepidermal water loss Effects 0.000 description 5
- 239000000341 volatile oil Substances 0.000 description 5
- 210000000170 cell membrane Anatomy 0.000 description 4
- 230000008859 change Effects 0.000 description 4
- 238000011161 development Methods 0.000 description 4
- 230000018109 developmental process Effects 0.000 description 4
- 230000004927 fusion Effects 0.000 description 4
- 230000003993 interaction Effects 0.000 description 4
- KQQKGWQCNNTQJW-UHFFFAOYSA-N linolenic acid Natural products CC=CCCC=CCC=CCCCCCCCC(O)=O KQQKGWQCNNTQJW-UHFFFAOYSA-N 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 229910052760 oxygen Inorganic materials 0.000 description 4
- 239000001301 oxygen Substances 0.000 description 4
- 239000002245 particle Substances 0.000 description 4
- 230000008569 process Effects 0.000 description 4
- 230000008929 regeneration Effects 0.000 description 4
- 238000011069 regeneration method Methods 0.000 description 4
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 3
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 3
- 241000218652 Larix Species 0.000 description 3
- 235000005590 Larix decidua Nutrition 0.000 description 3
- 229930003268 Vitamin C Natural products 0.000 description 3
- 239000004480 active ingredient Substances 0.000 description 3
- 239000013543 active substance Substances 0.000 description 3
- 239000003963 antioxidant agent Substances 0.000 description 3
- 230000003078 antioxidant effect Effects 0.000 description 3
- 235000006708 antioxidants Nutrition 0.000 description 3
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 3
- 229910002092 carbon dioxide Inorganic materials 0.000 description 3
- 235000021466 carotenoid Nutrition 0.000 description 3
- 150000001747 carotenoids Chemical class 0.000 description 3
- 235000012000 cholesterol Nutrition 0.000 description 3
- 231100000135 cytotoxicity Toxicity 0.000 description 3
- 230000003013 cytotoxicity Effects 0.000 description 3
- 238000009826 distribution Methods 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- VZCCETWTMQHEPK-QNEBEIHSSA-N gamma-linolenic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/CCCCC(O)=O VZCCETWTMQHEPK-QNEBEIHSSA-N 0.000 description 3
- 230000002209 hydrophobic effect Effects 0.000 description 3
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 230000002265 prevention Effects 0.000 description 3
- 238000003786 synthesis reaction Methods 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 210000001519 tissue Anatomy 0.000 description 3
- 229930003799 tocopherol Natural products 0.000 description 3
- 239000011732 tocopherol Substances 0.000 description 3
- 235000019154 vitamin C Nutrition 0.000 description 3
- 239000011718 vitamin C Substances 0.000 description 3
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 description 3
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 2
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 2
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 2
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 2
- 244000099147 Ananas comosus Species 0.000 description 2
- 235000007119 Ananas comosus Nutrition 0.000 description 2
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 208000010201 Exanthema Diseases 0.000 description 2
- 244000068988 Glycine max Species 0.000 description 2
- 235000010469 Glycine max Nutrition 0.000 description 2
- -1 Gondoic acid Octadecanoic acid Chemical compound 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 2
- 235000021355 Stearic acid Nutrition 0.000 description 2
- 206010000496 acne Diseases 0.000 description 2
- 230000032683 aging Effects 0.000 description 2
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 description 2
- ANVAOWXLWRTKGA-XHGAXZNDSA-N all-trans-alpha-carotene Chemical compound CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1C(C)=CCCC1(C)C ANVAOWXLWRTKGA-XHGAXZNDSA-N 0.000 description 2
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 235000013734 beta-carotene Nutrition 0.000 description 2
- 239000011648 beta-carotene Substances 0.000 description 2
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 description 2
- 229960002747 betacarotene Drugs 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 description 2
- 238000004113 cell culture Methods 0.000 description 2
- 230000001413 cellular effect Effects 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- 239000006185 dispersion Substances 0.000 description 2
- 201000005884 exanthem Diseases 0.000 description 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 229920002674 hyaluronan Polymers 0.000 description 2
- 229960003160 hyaluronic acid Drugs 0.000 description 2
- 230000036571 hydration Effects 0.000 description 2
- 238000006703 hydration reaction Methods 0.000 description 2
- 229930195733 hydrocarbon Natural products 0.000 description 2
- 150000002430 hydrocarbons Chemical class 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 2
- 230000003020 moisturizing effect Effects 0.000 description 2
- 230000001613 neoplastic effect Effects 0.000 description 2
- 239000000346 nonvolatile oil Substances 0.000 description 2
- 235000008935 nutritious Nutrition 0.000 description 2
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 2
- 239000004006 olive oil Substances 0.000 description 2
- 235000008390 olive oil Nutrition 0.000 description 2
- 235000020660 omega-3 fatty acid Nutrition 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- 229940094443 oxytocics prostaglandins Drugs 0.000 description 2
- 230000035790 physiological processes and functions Effects 0.000 description 2
- 239000000419 plant extract Substances 0.000 description 2
- 235000020777 polyunsaturated fatty acids Nutrition 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 150000003180 prostaglandins Chemical class 0.000 description 2
- 239000011241 protective layer Substances 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 230000005855 radiation Effects 0.000 description 2
- 206010037844 rash Diseases 0.000 description 2
- 210000001732 sebaceous gland Anatomy 0.000 description 2
- 210000002374 sebum Anatomy 0.000 description 2
- 210000004927 skin cell Anatomy 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- 235000019149 tocopherols Nutrition 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- 239000003053 toxin Substances 0.000 description 2
- 231100000765 toxin Toxicity 0.000 description 2
- 108700012359 toxins Proteins 0.000 description 2
- 238000012546 transfer Methods 0.000 description 2
- 230000032258 transport Effects 0.000 description 2
- 239000002691 unilamellar liposome Substances 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 2
- QUEDXNHFTDJVIY-UHFFFAOYSA-N γ-tocopherol Chemical class OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1 QUEDXNHFTDJVIY-UHFFFAOYSA-N 0.000 description 2
- DMASLKHVQRHNES-UPOGUZCLSA-N (3R)-beta,beta-caroten-3-ol Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C DMASLKHVQRHNES-UPOGUZCLSA-N 0.000 description 1
- JKQXZKUSFCKOGQ-JLGXGRJMSA-N (3R,3'R)-beta,beta-carotene-3,3'-diol Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)C[C@@H](O)CC1(C)C JKQXZKUSFCKOGQ-JLGXGRJMSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- 102100034544 Acyl-CoA 6-desaturase Human genes 0.000 description 1
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 description 1
- 241000024188 Andala Species 0.000 description 1
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- 241000222122 Candida albicans Species 0.000 description 1
- 241000167550 Centella Species 0.000 description 1
- 235000021538 Chard Nutrition 0.000 description 1
- 208000032544 Cicatrix Diseases 0.000 description 1
- 241000207199 Citrus Species 0.000 description 1
- 239000004212 Cryptoxanthin Substances 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 206010013786 Dry skin Diseases 0.000 description 1
- 235000017643 Elaeagnus angustifolia Nutrition 0.000 description 1
- 244000016119 Elaeagnus latifolia Species 0.000 description 1
- 235000001456 Elaeagnus latifolia Nutrition 0.000 description 1
- 235000007630 Elaeagnus umbellata var parvifolia Nutrition 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 208000001034 Frostbite Diseases 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- 229930186217 Glycolipid Natural products 0.000 description 1
- 244000020551 Helianthus annuus Species 0.000 description 1
- 235000003222 Helianthus annuus Nutrition 0.000 description 1
- 206010022714 Intestinal ulcer Diseases 0.000 description 1
- LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 description 1
- 108010037138 Linoleoyl-CoA Desaturase Proteins 0.000 description 1
- 239000000232 Lipid Bilayer Substances 0.000 description 1
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 1
- JEVVKJMRZMXFBT-XWDZUXABSA-N Lycophyll Natural products OC/C(=C/CC/C(=C\C=C\C(=C/C=C/C(=C\C=C\C=C(/C=C/C=C(\C=C\C=C(/CC/C=C(/CO)\C)\C)/C)\C)/C)\C)/C)/C JEVVKJMRZMXFBT-XWDZUXABSA-N 0.000 description 1
- 206010027476 Metastases Diseases 0.000 description 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
- 235000021319 Palmitoleic acid Nutrition 0.000 description 1
- XACHQDDXHDTRLX-XLVVAOPESA-N Physalien Chemical compound CC1(C)C[C@H](OC(=O)CCCCCCCCCCCCCCC)CC(C)=C1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)C[C@@H](OC(=O)CCCCCCCCCCCCCCC)CC1(C)C XACHQDDXHDTRLX-XLVVAOPESA-N 0.000 description 1
- XACHQDDXHDTRLX-GMPBGBGESA-N Physalien Natural products O=C(O[C@H]1CC(C)(C)C(/C=C/C(=C\C=C\C(=C/C=C/C=C(\C=C\C=C(/C=C/C=2C(C)(C)C[C@H](OC(=O)CCCCCCCCCCCCCCC)CC=2C)\C)/C)\C)/C)=C(C)C1)CCCCCCCCCCCCCCC XACHQDDXHDTRLX-GMPBGBGESA-N 0.000 description 1
- 241000218657 Picea Species 0.000 description 1
- CWEZAWNPTYBADX-UHFFFAOYSA-N Procyanidin Natural products OC1C(OC2C(O)C(Oc3c2c(O)cc(O)c3C4C(O)C(Oc5cc(O)cc(O)c45)c6ccc(O)c(O)c6)c7ccc(O)c(O)c7)c8c(O)cc(O)cc8OC1c9ccc(O)c(O)c9 CWEZAWNPTYBADX-UHFFFAOYSA-N 0.000 description 1
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 1
- 241000191940 Staphylococcus Species 0.000 description 1
- 229930182558 Sterol Natural products 0.000 description 1
- 208000007107 Stomach Ulcer Diseases 0.000 description 1
- 206010042496 Sunburn Diseases 0.000 description 1
- 102000019197 Superoxide Dismutase Human genes 0.000 description 1
- 108010012715 Superoxide dismutase Proteins 0.000 description 1
- 241000789545 Trimeria grandifolia Species 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 206010052428 Wound Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- JKQXZKUSFCKOGQ-LQFQNGICSA-N Z-zeaxanthin Natural products C([C@H](O)CC=1C)C(C)(C)C=1C=CC(C)=CC=CC(C)=CC=CC=C(C)C=CC=C(C)C=CC1=C(C)C[C@@H](O)CC1(C)C JKQXZKUSFCKOGQ-LQFQNGICSA-N 0.000 description 1
- QOPRSMDTRDMBNK-RNUUUQFGSA-N Zeaxanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCC(O)C1(C)C)C=CC=C(/C)C=CC2=C(C)CC(O)CC2(C)C QOPRSMDTRDMBNK-RNUUUQFGSA-N 0.000 description 1
- XACHQDDXHDTRLX-UHFFFAOYSA-N Zeaxanthin-dipalmitat Natural products CC1(C)CC(OC(=O)CCCCCCCCCCCCCCC)CC(C)=C1C=CC(C)=CC=CC(C)=CC=CC=C(C)C=CC=C(C)C=CC1=C(C)CC(OC(=O)CCCCCCCCCCCCCCC)CC1(C)C XACHQDDXHDTRLX-UHFFFAOYSA-N 0.000 description 1
- NENOAJSZZPODGJ-OIMNJJJWSA-N [(2r)-2-[(2r,3r,4s)-3,4-dihydroxyoxolan-2-yl]-2-hydroxyethyl] octanoate Chemical compound CCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O NENOAJSZZPODGJ-OIMNJJJWSA-N 0.000 description 1
- 238000011360 adjunctive therapy Methods 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 150000001299 aldehydes Chemical class 0.000 description 1
- 125000001931 aliphatic group Chemical group 0.000 description 1
- 125000000217 alkyl group Chemical group 0.000 description 1
- JKQXZKUSFCKOGQ-LOFNIBRQSA-N all-trans-Zeaxanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2=C(C)CC(O)CC2(C)C JKQXZKUSFCKOGQ-LOFNIBRQSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 229960000458 allantoin Drugs 0.000 description 1
- WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 description 1
- 239000011795 alpha-carotene Substances 0.000 description 1
- 235000003903 alpha-carotene Nutrition 0.000 description 1
- ANVAOWXLWRTKGA-HLLMEWEMSA-N alpha-carotene Natural products C(=C\C=C\C=C(/C=C/C=C(\C=C\C=1C(C)(C)CCCC=1C)/C)\C)(\C=C\C=C(/C=C/[C@H]1C(C)=CCCC1(C)C)\C)/C ANVAOWXLWRTKGA-HLLMEWEMSA-N 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000000843 anti-fungal effect Effects 0.000 description 1
- 230000001153 anti-wrinkle effect Effects 0.000 description 1
- 229940121375 antifungal agent Drugs 0.000 description 1
- 239000002543 antimycotic Substances 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 235000021028 berry Nutrition 0.000 description 1
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 1
- 235000002360 beta-cryptoxanthin Nutrition 0.000 description 1
- DMASLKHVQRHNES-ITUXNECMSA-N beta-cryptoxanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2=C(C)CCCC2(C)C DMASLKHVQRHNES-ITUXNECMSA-N 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 229960001948 caffeine Drugs 0.000 description 1
- VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 description 1
- 229940095731 candida albicans Drugs 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 150000001765 catechin Chemical class 0.000 description 1
- ADRVNXBAWSRFAJ-UHFFFAOYSA-N catechin Natural products OC1Cc2cc(O)cc(O)c2OC1c3ccc(O)c(O)c3 ADRVNXBAWSRFAJ-UHFFFAOYSA-N 0.000 description 1
- 235000005487 catechin Nutrition 0.000 description 1
- 210000002390 cell membrane structure Anatomy 0.000 description 1
- 229940106189 ceramide Drugs 0.000 description 1
- 150000001783 ceramides Chemical class 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000002512 chemotherapy Methods 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 235000020971 citrus fruits Nutrition 0.000 description 1
- 239000008406 cosmetic ingredient Substances 0.000 description 1
- 235000019244 cryptoxanthin Nutrition 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 150000003999 cyclitols Chemical class 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 235000015872 dietary supplement Nutrition 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 231100000673 dose–response relationship Toxicity 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000037336 dry skin Effects 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000002183 duodenal effect Effects 0.000 description 1
- 208000000718 duodenal ulcer Diseases 0.000 description 1
- 230000001804 emulsifying effect Effects 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 239000012091 fetal bovine serum Substances 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 229960000304 folic acid Drugs 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- 238000013467 fragmentation Methods 0.000 description 1
- 238000006062 fragmentation reaction Methods 0.000 description 1
- 235000021022 fresh fruits Nutrition 0.000 description 1
- 230000004345 fruit ripening Effects 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 235000012055 fruits and vegetables Nutrition 0.000 description 1
- 125000000524 functional group Chemical group 0.000 description 1
- 229930182830 galactose Natural products 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 230000000762 glandular Effects 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 125000005456 glyceride group Chemical group 0.000 description 1
- 150000002314 glycerols Chemical class 0.000 description 1
- 238000009499 grossing Methods 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 229940093915 gynecological organic acid Drugs 0.000 description 1
- KYYWBEYKBLQSFW-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O.CCCCCCCCCCCCCCCC(O)=O KYYWBEYKBLQSFW-UHFFFAOYSA-N 0.000 description 1
- 230000003054 hormonal effect Effects 0.000 description 1
- 210000005260 human cell Anatomy 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000025563 intercellular transport Effects 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 150000002617 leukotrienes Chemical class 0.000 description 1
- 239000007791 liquid phase Substances 0.000 description 1
- 150000004668 long chain fatty acids Chemical class 0.000 description 1
- 235000012661 lycopene Nutrition 0.000 description 1
- 239000001751 lycopene Substances 0.000 description 1
- OAIJSZIZWZSQBC-GYZMGTAESA-N lycopene Chemical compound CC(C)=CCC\C(C)=C\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C=C(/C)CCC=C(C)C OAIJSZIZWZSQBC-GYZMGTAESA-N 0.000 description 1
- 229960004999 lycopene Drugs 0.000 description 1
- 239000002075 main ingredient Substances 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 239000011976 maleic acid Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000037306 mature skin Effects 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 230000009245 menopause Effects 0.000 description 1
- 230000004066 metabolic change Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 230000009401 metastasis Effects 0.000 description 1
- 230000002906 microbiologic effect Effects 0.000 description 1
- 238000012543 microbiological analysis Methods 0.000 description 1
- 210000001700 mitochondrial membrane Anatomy 0.000 description 1
- VMGAPWLDMVPYIA-HIDZBRGKSA-N n'-amino-n-iminomethanimidamide Chemical compound N\N=C\N=N VMGAPWLDMVPYIA-HIDZBRGKSA-N 0.000 description 1
- 230000001537 neural effect Effects 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 235000021315 omega 9 monounsaturated fatty acids Nutrition 0.000 description 1
- PJHOFUXBXJNUAC-UHFFFAOYSA-N omega7-palmitoleic acid Natural products CCCCCCCCC=CCCCCCC(O)=O PJHOFUXBXJNUAC-UHFFFAOYSA-N 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 238000006213 oxygenation reaction Methods 0.000 description 1
- SECPZKHBENQXJG-FPLPWBNLSA-N palmitoleic acid group Chemical class C(CCCCCCC\C=C/CCCCCC)(=O)O SECPZKHBENQXJG-FPLPWBNLSA-N 0.000 description 1
- 238000010951 particle size reduction Methods 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 125000002467 phosphate group Chemical group [H]OP(=O)(O[H])O[*] 0.000 description 1
- WTJKGGKOPKCXLL-RRHRGVEJSA-N phosphatidylcholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCCC=CCCCCCCCC WTJKGGKOPKCXLL-RRHRGVEJSA-N 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 150000008442 polyphenolic compounds Chemical class 0.000 description 1
- 235000013824 polyphenols Nutrition 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 235000021085 polyunsaturated fats Nutrition 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- 229920002414 procyanidin Polymers 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- QQONPFPTGQHPMA-UHFFFAOYSA-N propylene Natural products CC=C QQONPFPTGQHPMA-UHFFFAOYSA-N 0.000 description 1
- 125000004805 propylene group Chemical group [H]C([H])([H])C([H])([*:1])C([H])([H])[*:2] 0.000 description 1
- 150000003815 prostacyclins Chemical class 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 238000001959 radiotherapy Methods 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000003716 rejuvenation Effects 0.000 description 1
- BOLDJAUMGUJJKM-LSDHHAIUSA-N renifolin D Natural products CC(=C)[C@@H]1Cc2c(O)c(O)ccc2[C@H]1CC(=O)c3ccc(O)cc3O BOLDJAUMGUJJKM-LSDHHAIUSA-N 0.000 description 1
- 238000007665 sagging Methods 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 238000010963 scalable process Methods 0.000 description 1
- 231100000241 scar Toxicity 0.000 description 1
- 230000037387 scars Effects 0.000 description 1
- 229930000044 secondary metabolite Natural products 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 238000013207 serial dilution Methods 0.000 description 1
- 239000002453 shampoo Substances 0.000 description 1
- 231100000075 skin burn Toxicity 0.000 description 1
- 230000037380 skin damage Effects 0.000 description 1
- 208000017520 skin disease Diseases 0.000 description 1
- 230000037394 skin elasticity Effects 0.000 description 1
- 230000037393 skin firmness Effects 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 235000003702 sterols Nutrition 0.000 description 1
- 150000003432 sterols Chemical class 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 239000010902 straw Substances 0.000 description 1
- 230000036561 sun exposure Effects 0.000 description 1
- 238000000194 supercritical-fluid extraction Methods 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 230000009897 systematic effect Effects 0.000 description 1
- 239000001648 tannin Substances 0.000 description 1
- 235000018553 tannin Nutrition 0.000 description 1
- 229920001864 tannin Polymers 0.000 description 1
- 150000003505 terpenes Chemical class 0.000 description 1
- 235000007586 terpenes Nutrition 0.000 description 1
- 150000003595 thromboxanes Chemical class 0.000 description 1
- 235000010384 tocopherol Nutrition 0.000 description 1
- 229960001295 tocopherol Drugs 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 231100000563 toxic property Toxicity 0.000 description 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 1
- ZCIHMQAPACOQHT-ZGMPDRQDSA-N trans-isorenieratene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/c1c(C)ccc(C)c1C)C=CC=C(/C)C=Cc2c(C)ccc(C)c2C ZCIHMQAPACOQHT-ZGMPDRQDSA-N 0.000 description 1
- KBPHJBAIARWVSC-XQIHNALSSA-N trans-lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C KBPHJBAIARWVSC-XQIHNALSSA-N 0.000 description 1
- 230000001228 trophic effect Effects 0.000 description 1
- 235000021081 unsaturated fats Nutrition 0.000 description 1
- 230000017260 vegetative to reproductive phase transition of meristem Effects 0.000 description 1
- 210000003501 vero cell Anatomy 0.000 description 1
- 230000035899 viability Effects 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
- 235000010930 zeaxanthin Nutrition 0.000 description 1
- 239000001775 zeaxanthin Substances 0.000 description 1
- 229940043269 zeaxanthin Drugs 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/678—Tocopherol, i.e. vitamin E
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/14—Liposomes; Vesicles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
- A61K8/361—Carboxylic acids having more than seven carbon atoms in an unbroken chain; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/37—Esters of carboxylic acids
- A61K8/375—Esters of carboxylic acids the alcohol moiety containing more than one hydroxy group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
- A61K8/4946—Imidazoles or their condensed derivatives, e.g. benzimidazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
- A61K8/4953—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom containing pyrimidine ring derivatives, e.g. minoxidil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/55—Phosphorus compounds
- A61K8/553—Phospholipids, e.g. lecithin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/63—Steroids; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/735—Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
- A61K8/922—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Dermatology (AREA)
- Cosmetics (AREA)
Abstract
Bu buluş lipozomal teknoloji kullanarak enkapsüle edilen Yabani iğde ekstresinin ile hazırlanan, yenileyici kişisel bakım ürünleri formülasyonları ve bunların üretim yöntemi ile ilgilidir. Yabani iğde yağının fosfolipid ile enkapsüle edilmesi için Microfludizer sistemi kullanılmaktadır. Formülasyon bünyesinde, ayrıca, cildin yenilenmesi ve onarılması için Palmito-oleik asit (omega-7) ve ϒ#&-linolenik asit (omega-6) gibi doymamış yağ asitleri içeriği bulunmaktadır.This invention relates to formulations of regenerative personal care products prepared with the extract of Sea buckthorn encapsulated using liposomal technology and their production method. Microfludizer system is used to encapsulate wild sequin oil with phospholipid. The formulation also contains unsaturated fatty acids such as Palmito-oleic acid (omega-7) and ϒ#&-linolenic acid (omega-6) for skin regeneration and repair.
Description
TARIFNAME KOZMETIK FORMÜLLERDE KULLANMAK ÜZERE LIPOZOMAL TEKNOLOJI ILE ENKAPSÜLE EDILMIS YABANI IGDE (HIPPOPHAE RHAMNOIDES) EKSTRESININ ELDE EDILME YÖNTEMI Teknik Alan Bu bulus lipozoirial teknoloji kullanarak enkapsüle edilen Yabani igde ekstresinin ile hazirlanan, yenileyici etkiye sahip kisisel bakim ürünleri formülasyonlari ile Önceki Teknik Yabani igde (Hgvpophae rhamnoides) yagi omega-7 palmitoleik asit açisindan en zengin kaynaklardan biridir, karotenoidler ve tokoferoller içerir. Bu nedenle kozmetik fomüllerde ve gida takviyelerinde tohumundan, meyvelerinden ve yapraklarindan elde edilen ekstresi natural haliyle kullanilmaktadir [1], [2]. DESCRIPTION LIPOSOMAL FOR USE IN COSMETIC FORMULAS WILD IGDE (HIPPOPHAE) ENCAPSULATED WITH TECHNOLOGY RHAMNOIDES) EXTRACT METHOD Technical Area This invention is based on the extract of Wild igdese encapsulated using lipozoirial technology. With personal care product formulations with regenerative effect, prepared with Prior Art Wild larch (Hgvpophae rhamnoides) oil is the most abundant in terms of omega-7 palmitoleic acid. It is one of the richest sources, contains carotenoids and tocopherols. Because from its seeds, fruits and vegetables in cosmetic formulas and food supplements. The extract obtained from the leaves is used in its natural form [1], [2].
Bitkilerden elde edilen sabit ve uçucu yaglar (EO) dogal, kompleks bilesiklerdir. Fixed and essential oils (EO) obtained from plants are natural, complex compounds.
Sekonder metabolitler olarak aromatik bitkilerin yapisinda bulunurlar. They are found in the structure of aromatic plants as secondary metabolites.
Tomurcuklar, çiçekler gibi tüm bitki organlari tarafindan sentezlenebilir, yapraklar, saplar, dallar, tohumlar, meyveler, kökler, agaç veya agaç kabugu ve salgi hücrelerinde, bosluklarda, kanallarda, epidermik hücrelerde veya glandüler trikomlarda bulunurlar. Terpenler dahil mono-, sesqui- ve di-terpenler uçucu yaglarin esas moleküllerindendir. Bu yaglar, antifungal, antioksidan ve bakterisit Vb biyolojik etkileri nedeniyle genis bir yelpazeye sahiptir. Bu nedenle, son yillarda uçucu ve sabit yaglarin gida sanayi ve eczacilikta kullanimi giderek artmaktadir. It can be synthesized by all plant organs such as buds, flowers, leaves, stems, branches, seeds, fruits, roots, tree or bark and secretion cells, spaces, ducts, epidermic cells or glandular are found in trichomes. Mono-, sesqui- and di-terpenes, including terpenes, are volatile It is one of the main molecules of oils. These oils are antifungal, antioxidant and bactericidal. It has a wide range due to its biological effects. Therefore, in recent years The use of essential and fixed oils in the food industry and pharmacy is increasing.
Ancak, iyi bilinmektedir ki çogu bitkisel yag biyolojik olarak stabil degildir. However, it is well known that most vegetable oils are not biologically stable.
Oksijen, isik ve sicakliga duyarlidirlar. Bazi uçucu yaglar oksijenin etkilenen kararsiz fonksiyonel gruplari içerir, alkoller ve aldehitler için oksijen oksitleyici olabildigi gibi, radyasyon doymamis monoterpenik ve seskiterpenik 25418.101 hidrokarbonlarin yapisini degistirebilir. Ek olarak, yaglann suda çözünmesi zayiftir. Bu nedenle enkapsülasyon yöntemi, bitkisel yaglarin çözünürlüklerini ve biyoyararlanimlarini artirmak, ayni zamanda, serbest birakilmalarini kontrol ederek, etkinliklerini artirmak üzere kullanilmaktadir. Lipid vezikül membraninin bilesimi, özellikle fosfolipidlerin tipi, kolesterol içerigi, uçucu yaglarin lipitlere molar orani, hazirlama yöntemi ve Çesitleri lipozom boyutunu ve kapsülleme verimliligini etkileyebilir. Uçucu yaglar lipozomlarin boyutunu küçültebilir, lipozomal dispersiyonlari homojenlestirebilir, akiskanligi arttirabilir ve lipit tabakasinin oksidasyonunu azaltabilir [3]. They are sensitive to oxygen, light and temperature. Some essential oils are affected by oxygen Contains labile functional groups, oxidizing oxygen for alcohols and aldehydes as possible, radiation unsaturated monoterpenic and sesquiterpenic 25418.101 can change the structure of hydrocarbons. In addition, the solubility of oils in water it is weak. For this reason, the encapsulation method determines the solubility and solubility of vegetable oils. increase their bioavailability, at the same time control their release are used to increase their effectiveness. lipid vesicle membrane composition, especially the type of phospholipids, cholesterol content, molar ratio, preparation method and Types liposome size and encapsulation may affect its efficiency. Essential oils can reduce the size of liposomes, It can homogenize liposomal dispersions, increase fluidity and lipid It can reduce the oxidation of the layer [3].
Yapilan bir çalismada Yabani igde yapraklarindan superkritik karbon dioksit yöntemiyle elde edilen ekstresinin enkapsüle edilmesi sonucunda, antioksidan aktivitenin ayni bitkilerden elde edilen ekstreye göre daha yüksek oldugu kanitlanmistir [2]. In a study, supercritical carbon dioxide from wild spruce leaves As a result of encapsulation of the extract obtained by the method, antioxidant activity was higher than the extract obtained from the same plants. has been proven [2].
Bitkisel yaglar, zengin bir yag asidi kaynagi olarak tibbi ve kozmetik ürünler pazarinda yerini almistir [4], [5], [6], [7], [8], [9]. Bu yaglarda bulunan yag asitleri cilt üzerinde transepidermal su kaybini (TEWL) azaltan bariyer bir film olusturur, böylece epidermisin dogru sekilde hidrasyonunun korunmasina katkida bulunur yumusatir, böylece cildin hücre içi yapisinin devamligina katkida bulunur [6], [7], olarak, yaglarin cilt ve insan sagligi üzerindeki etkisi degisebilir [4], [5], [6], [7]. Örnegin, lipid eksikligi cildin yeterli koruyucu tabakadan mahrum kalmasina ve kurumasina neden olur [9]. Vegetable oils, medicinal and cosmetic products as a rich source of fatty acids [4], [5], [6], [7], [8], [9]. The fatty acids found in these oils forms a barrier film on the skin that reduces transepidermal water loss (TEWL), thus contributing to maintaining the correct hydration of the epidermis. softens, thus contributing to the continuity of the intracellular structure of the skin [6], [7], Additionally, the effect of oils on skin and human health may vary [4], [5], [6], [7]. For example, lipid deficiency causes the skin to be deprived of an adequate protective layer and causes drying [9].
Bitkisel yaglarin, kozmetik ürünlerdeki temel içeriklerden biri olinasinin nedeni, esas olarak epidermisi kaplayan bariyer bir film olusturarak cilt yoluyla asiri su kaybina karsi korumasi yani cildin nemliligini saglamasidir [6], [7], [9]. 25418.101 Uzun zincirli yag asitleri olan trigliseritler, insan vücudunun uygun isleyisinde önemli bir rol oynar [4], [5], [7], [10]. Bitkisel yaglar, hücre zari bilesenlerinin veya ekosanoidlerin (ekosanoidler: prostaglandinler, prostasiklinler, tromboksanlar, lökotrienler) biyolojik sentezinde önemli bir rol oynar [6]. The reason why vegetable oils are one of the main ingredients in cosmetic products, excess water through the skin by forming a barrier film that mainly covers the epidermis It is the protection against the loss of skin, that is, it provides the moisture of the skin [6], [7], [9]. 25418.101 Triglycerides, which are long chain fatty acids, are essential for the proper functioning of the human body. plays an important role [4], [5], [7], [10]. Vegetable oils, cell membrane components or ecosanoids (ecosanoids: prostaglandins, prostacyclins, thromboxanes, leukotrienes) plays an important role in its biological synthesis [6].
Dogal gliseritlerden biri, zengin bir kimyasal bilesime ve benzersiz özelliklere sahip yoluyla meyveden veya bitkinin tohumlarindan ekstraksiyonu ile elde edilir [15]. One of the natural glycerides, with a rich chemical composition and unique properties It is obtained by extraction from the fruit or the seeds of the plant [15].
En son bilimsel çalismalar, antioksidanlar, C vitamini, flavonoidler, polisakkaritler ve polifenoller de dahil olmak üzere, bitkinin meyvesinden soguk ekstraksiyon ile elde edilen Y. igde (Hippophaes rhamnoides) ekstraktindaki birçok aktif` maddenin varligini dogrulamaktadir. Günümüzde hem Y. igde (F mcrus Hippophae) meyvesi hem de tohumlari (Saman Hippaphae) sadece gida endüstrisi için kullanilan bir hammadde degil ayni zamanda cilt için faydalari nedeniyle kozmetik ürünlerinin faydali bir bilesenidir [15]. The latest scientific studies, antioxidants, vitamin C, flavonoids, polysaccharides by cold extraction from the fruit of the plant, including polyphenols Many active substances in Y. igde (Hippophaes rhamnoides) extract confirms its existence. Today, both Y. igde (F mcrus Hippophae) fruit and its seeds (Straw Hippaphae) are used only for the food industry. of cosmetic products not only because of its raw material but also because of its benefits for the skin. It is a useful component [15].
Y. igde (Hippophaes rhamnoides) botanik açiklamasi: Sibirya ananasi olarak da bilinen yaygin Y. igde (Hippophaes rhanmofdes), oleaster ailesinde (Elaeagnaceae) 7 m yükseklige kadar büyüyen dikenli bir çalidir (veya agaç) [15], [19], [20]. Düz veya bazen çatlamis bir kabugu vardir. Bitki Avrupa, Kafkaslar, Asya, Sibirya, Çin ve Tibet'te yetisir [19], [22], [23]. Y. igde geç nisan ve mayis aylarinin baslarinda çiçeklenir. Bitkinin, altinda gümüsi tüylerle kaplanmis uzun mizrak seklinde yapraklari vardir. Çali, salkim seklinde çok sayida küçük, yesil ve kahverengi çiçek üretir. Çiçeklenme döneminden sonra, Eylül ayinda olgunlasan, genellikle sari veya turuncu olan, lezzetli ve besleyici yuvarlak meyvelere dönüsürler. Meyvenin içinde uzun bir oluk bulunan ve yagli bir tohumu i gde meyveleri aci ve eksidir, ananasinkine benzeyen hassas bir aromasi vardir [1 51, mg), fakat ayni zamanda alfa ve beta-karoten (% 60 mg'a kadar) olan A vitamini ve 25418.101 diger karotenoidlerin bir karisimini içerir (toplamda % 180 mg'a kadar). Ayrica, meyvelerde tokoferoller, E vitamini (% 110 ila 160 mg), folik asit (% 0.79 mg'a Vitamini, katesinler ve prosiyanidinler, siklitoller, fosfolipitler, tanenler, karbohidratlar (galaktoz, fruktoz, ksiloz, yak. % 3.9), organik asitler (maleik asit, ve cografi konumuna baglidir. Örnegin, kiyi kumullarinda Avrupa'da yetisen Y. igde, taze meyvelerde % 120-315 mg C vitamini içerirken Alplerde yetisen türler Sinemis) askorbik asit içerigi % 2500 mg'a kadar olan C vitamini bakimindan en etkisine sahip karotenoidlerin içerigi de yüksektir. Beta-karoten içerigi % 40-100 mg arasindadir ve likopen, kriptoksantin, physalien, zeaksantin gibi diger Meyveleri preslendiginde elde edilen meyve suyu üç tabakaya ayrilir. Üst tabaka kalin bir Citrus tabakasidir, orta tabaka doymus ve doymamis yag asitlerinin bir karisimini içerir ve alt tabaka kozmetik amaçli kullanilan bir yag kaynagi olan tabakadir [34], [35], [36], [37]. Cilt bakim kremlerinin yapiminda iki üst katman islenebilir ve kullanilabilir ve alt katman genellikle gida endüstrisinde surup olarak kullanilir. Günümüzde, yaygin Y. igde meyvelerinin yüksek besleyici bilesenleri, tipta, örnegin iltihaplarm, kanserlerin tedavisinde ve kemoterapiden sonra ek tedavi Y. igde kabugu ve yapraklari diyare ve dermatolojik durumlarin tedavisinde kullanilirken, topikal olarak uygulanan veya agizdan alinan yagi Cildi yumusatir Içeriklerin Kimyasal bilesimi 25418.101 Y. igde meyve yagi, diger bitkisel yaglara kiyasla benzersiz bir yag asidi içerigine sahiptir [45], [46], [47]. Özellikle, bu yagin cilt lipidlerinin bir bileseni olan ve epidermis ve yara iyilesmesinde rejeneratif` süreçleri uyaran nadir palmitooleik asit (omega-7) içerdigine dikkat edilmelidir. Bu sayede Y. igde yagi fizyolojik Cilt fonksiyonlarini harekete geçirir ve yara izlerini azaltir [48], [49], [50]. Oral olarak kullanildiginda, mide, duodenal ve bagirsak ülserlerinin tedavisini destekler, topikal olarak yatistirir, cilt yaniklarini (günese maruz kalma veya radyoterapinin neden oldugu), sürtünmeden dolayi irrite olmus cildi, yaralari ve trofik deri degisikliklerini azaltir ve cildi sakinlestirir [48], [49], [50]. Ek olarak, Y. igde yagi, asitleri içerir ve özellikle PUFA (çoklu doymamis yag asitleri) olarak adlandirilan yag asitleri içerir [15], [45], [46], [47]. Bunlar arasinda alfa-linolenik asit (omega- Numerical symbol General formula Content in Common name Systematic name family Saturated fatty acids Palmitic acid Hexadecanoic acid MCOO C16:0 Stearic acid Unsatu rated fatty Palmiioleic acid Oleic acid Linoleic acid (LA) o-Linolenic acid y-Iinolenic acid Gondoic acid Octadecanoic acid (2)-9-hexadecenoic acid (2)-9-0ctadecenoic acid (Z,Z)-9,12-0ctadecadienoic (Z,Z,Z)-9,12,15- octadecatrienoic (Z,Z,Z)-6,9,12~ octadecatrienoic (Z)-11-eicosen0ic acid -35 14-18 CH3(CH2)15COO C16H3002 C18H3402 C1BH32O2 C1BH3002 CîßHBÜOZ C18:0 Tablo 1 Yabani igdc yaginda bulunan yag asitlerinin kompozisyonu Bu kadar yüksek y-linolenik asit (GLA) içerigi, besinlerin tasinmasi üzerinde önemli bir etkiye sahiptir. GLA ayni zamanda cilt için çok önemli bir bilesendir, çünkü hücreler arasi yapi bileseni olarak epidermis hücrelerini baglar. Ayni zamanda hücre zarlarini olusturan fosfolipidlerin bilesiminde bulunur [17], [18]. y- 25418.101 linolenik asit, ciltte kan dolasimini artirir ve bunun sonucunda cilt yapisini, görünümünü ve tonunu iyilestiren fazla toksinleri giderir. Y. igde yaginda bulunan GLA, prostaglandinlere dönüstügünde daha derin cilt katmanlarina kolayca nüfuz eder. Bu nedenle, GLA deriyi enfeksiyonlara karsi etkili bir sekilde korur, alerjilere karsi koyar, iltihaplari hafifletir ve yaslanma sürecini yavaslatir [51], [52]. Omega- 6 asidinden yoksun kalan cilt daha kuru, daha az elastik ve herhangi bir lezyona duyarli hale gelir [52]. Hücreler arasi maddenin bir bileseni olan linoleik asidin (omega-6) varligi, hücresel yenilenmeyi tesvik eder ve cilt yag bezlerinin fonksiyonlarini düzenler [53]. Öte yandan, yüksek oranda doymus yag asidi içerigi (% 30'un üstünde), epidermisi yumusatmasina ve transepidermal su kaybina karsi Doymus yag asitleri Bitkisel yaglarda en yaygin doymus yag asitleri palmitik, stearik, miristik ve arasidik yag asitleridir. Yagin yüksek stabilitesini ve oksidasyona karsi direncini saglarlar [6]. Y. igde yagi palmitik ve stearik asitler içerir [6], [15]. Bu asitler cilt üzerinde koruyucu bir bariyerin etkisini güçlendiren koruyucu bir tabaka olusturur. Botanical description of Y. igde (Hippophaes rhamnoides): Common Y. igde (Hippophaes rhanmofdes), also known as Siberian pineapple, oleaster It is a thorny shrub (or tree) [15], [19], [20]. It has a flat or sometimes cracked bark. plant Europe, It grows in the Caucasus, Asia, Siberia, China and Tibet [19], [22], [23]. Y. igde late April and blooms in early May. The plant, with silvery hairs underneath It has coated long lanceolate leaves. Bush, many in the form of bunches produces small, green and brown flowers. After the flowering period, September Tasty and nutritious round fruit ripening in the month, usually yellow or orange they turn into fruits. An oily seed with a long groove inside the fruit Igde fruits are bitter and minty, with a delicate aroma similar to that of pineapple [1 51, mg), but also vitamin A with alpha and beta-carotene (up to 60 mg), and 25418.101 Contains a mixture of other carotenoids (up to 180 mg% in total). Moreover, tocopherols in fruits, vitamin E (from 110 to 160 mg), folic acid (to 0.79 mg) Vitamin, catechins and procyanidins, cyclitols, phospholipids, tannins, carbohydrates (galactose, fructose, xylose, approx. 3.9%), organic acids (maleic acid, and geographical location. For example, Y. igde contains 120-315 mg of vitamin C in fresh fruits, while species grown in the Alps Sinemis) is the most abundant vitamin C with ascorbic acid content up to 2500 mg%. It also has a high content of carotenoids that have an effect. Beta-carotene content 40-100% mg and other lycopene, cryptoxanthin, physalien, zeaxanthin. The juice obtained when the fruits are pressed is divided into three layers. top layer is a thick layer of Citrus, the middle layer is a mixture of saturated and unsaturated fatty acids. contains a mixture and the substrate is an oil source used for cosmetic purposes. layer [34], [35], [36], [37]. Two top layers in the production of skin care creams can be processed and used, and the substrate is often used as a syrup in the food industry. used. Today, the highly nutritious components of common Y. igde fruits, adjunctive therapy, for example in the treatment of inflammations, cancers and after chemotherapy Y. igdem bark and leaves for the treatment of diarrhea and dermatological conditions While using, oil that is applied topically or taken orally softens the skin. Chemical composition of ingredients 25418.101 Y. igde oil has a unique fatty acid content compared to other vegetable oils. [45], [46], [47]. In particular, this oil is a component of skin lipids and rare palmitooleic acid that stimulates regenerative processes in the epidermis and wound healing It should be noted that it contains (omega-7). In this way, Y. igdem oil is physiological. activates its functions and reduces scars [48], [49], [50]. orally when used, it supports the treatment of stomach, duodenal and intestinal ulcers, Topically soothes skin burns (sun exposure or radiation therapy). Caused by friction), irritated skin, wounds and trophic skin from friction changes and calms the skin [48], [49], [50]. In addition, Y. igde oil, contains acids and especially so-called PUFA (polyunsaturated fatty acids). contains fatty acids [15], [45], [46], [47]. These include alpha-linolenic acid (omega- numerical symbols General formula Content in Common name Systematic name family Saturated fatty acids Palmitic acid Hexadecanoic acid MCOO C16:0 stearic acid Unsatu rated fatty Palmiioleic acid oleic acid Linoleic acid (LA) o-Linolenic acid y-Iinolenic acid Gondoic acid Octadecanoic acid (2)-9-hexadecenoic acid (2)-9-0ctadecenoic acid (Z,Z)-9,12-0ctadecadienoic (Z,Z,Z)-9,12,15- octadecatrienoic (Z,Z,Z)-6,9,12~ octadecatrienoic (Z)-11-eicosen0ic acid -35 14-18 CH3(CH2)15COO C16H3002 C18H3402 C1BH32O2 C1BH3002 CîßHBÜOZ C18:0 Table 1 Composition of fatty acids in wild igdc oil Such high y-linolenic acid (GLA) content has an impact on the transport of nutrients. has a significant impact. GLA is also a very important component for the skin, because it binds the epidermis cells as an intercellular structural component. Same It is also found in the composition of phospholipids that form cell membranes [17], [18]. y- 25418.101 Linolenic acid increases blood circulation in the skin and as a result, skin structure, removes excess toxins improving appearance and tone. found in Y. igde oil GLA easily penetrates deeper skin layers when converted to prostaglandins. it does. Therefore, GLA effectively protects the skin against infections, counteracts, relieves inflammation and slows down the aging process [51], [52]. Omega- The skin deprived of 6 acids is drier, less elastic and prone to any lesions. becomes sensitive [52]. Linoleic acid, a component of intercellular substance The presence of (omega-6) promotes cellular regeneration and stimulates skin sebaceous glands. regulates its functions [53]. On the other hand, the high content of saturated fatty acids (above 30%) against softening of the epidermis and transepidermal water loss Saturated fatty acids The most common saturated fatty acids in vegetable oils are palmitic, stearic, myristic and are aracidic fatty acids. High stability of oil and resistance to oxidation. they provide [6]. Y. larch oil contains palmitic and stearic acids [6], [15]. These acids are It forms a protective layer on it, which strengthens the effect of a protective barrier.
Derinin esnekligini ve sikiligini saglarlar ve pürüzsüzlestirici ve yumusatici Doymamis yag asitleri Bu asit grubu, çift bag içeren yag asitlerini içerir. Çogunda, tüm çift baglar bir cis konfigürasyonundadir [6]. Günümüzde, iki ana doymamis yag asidi sinifi ayirt edilmektedir, Tekli doymamis FA (omega-9; (9-9, n-9 asitler) ve çoklu doymamis FA (omega-6; (ii-6; n-6 asitler). Çoklu doymamis FA, bir alkil zincirinde en az iki çift baga ve 18 karbon atomuna sahiptir [6]. Y. igde yagi, bazi enzimlerin eksikliginden dolayi bir insan vücudu tarafindan üretilemeyen bu grup linoliek asit (LA) ve alfa-linolenik asit (ALA) içerir. Yagda bulunan diger çoklu doymamis asitler, yani y-linolenik asit, oleik asit ve palmitoleik asitler, metabolik degisiklikler sirasinda vücutta ilgili enzim bulundugundan vücut tarafindan üretilebilir [6], [15]. They provide the elasticity and firmness of the skin and are smoothing and softening. Unsaturated fatty acids This acid group includes fatty acids with double bonds. For the most part, all double bonds are a cis in the configuration [6]. Today, two main classes of unsaturated fatty acids can be distinguished. Monounsaturated FA (omega-9; (9-9, n-9 acids) and polyunsaturated FA (omega-6; (ii-6; n-6 acids). Polyunsaturated FA has at least two in an alkyl chain it has a double bond and 18 carbon atoms [6]. Y. lard oil, some enzymes This group of linoleic acid, which cannot be produced by a human body due to its deficiency (LA) and alpha-linolenic acid (ALA). Other polyunsaturated fat acids, namely y-linolenic acid, oleic acid and palmitoleic acids, metabolic changes It can be produced by the body as the relevant enzyme is present in the body [6], [15].
Linoliek asidin bu gruptaki diger asitler gibi tüm omega-6 asitleri arasinda en 25418.101 önemlisi oldugu kabul edilir, ALA veya GLA7nin sentezinde rol oynar [6], [10], Komplex lipitler Y. igde yagi ayrica asagidakileri içeren kompleks lipitler içerir: Cildin nemlendirilmesini ve yumusatilmasini saglayan, epiderinisi yumusatan, cildin esnekligini artiran, cildin iltihabini azaltan, cilt yenileninesini ve hücre yenilenmesini hizlandiran fosfolipitler ve glikolipitler. Örnegin, fosfolipid grubuna ait olan lesithin (ayrica fosfatidilkolin olarak da bilinir), cildi yenileyici ve nemlendirici özelliklere sahiptir, yaslanma sürecini yavaslatir ve ayrica saçtaki asiri yagi (sebum) uzaklastirir. Shugam ve arkadaslarina göre, Y. igde yagi içindeki toplam fosfolipid içerigi agirlikça % 1'dir. Bu yagdaki lesitin içerigi, ince tabaka kromatografîsi ile tespit edilmistir [57]. Diger bilimsel arastirmalar [58], Y. igde perikarpindan elde edilen yagin agirlikça % 0.2-0.5 ila % 1 fosfolipid içerdigini dogrulamistir. Bunlardan agirlik olarak % 5,8'i lesithindir. Cildin lipit bariyerini güçlendiren steroller, dis kaynakli zararli maddelerden korur ve epidermis yoluyla asiri su kaybini azaltir, böylece cilt elastikiyetini ve sikiligini arttirir [59], [60]. Y. igde yagi içerisinde, az miktarda (agirlikça% l'den az) lipozomlarin varliginin kanitlanmis olmasi, aktif maddelerin yani sira cildin sikilastirilmasini ve cildi pürüzsüzlestirmesini saglayan seramidlerle baglanmasina olanak saglamistir [61]. Linoleic acid, like other acids in this group, is the most important among all omega-6 acids. 25418.101 It is considered to be important, plays a role in the synthesis of ALA or GLA7 [6], [10], complex lipids Y. lard oil also contains complex lipids including: moisturizing and softening the skin, softening the epidermis, increases its elasticity, reduces inflammation of the skin, promotes skin regeneration and cell phospholipids and glycolipids that accelerate regeneration. For example, the phospholipid group lecithin (also known as phosphatidylcholine), skin regenerating and It has moisturizing properties, slows down the aging process and also removes excess hair from the hair. removes oil (sebum). According to Shugam et al., the content of Y. igdem oil the total phospholipid content is 1% by weight. The lecithin content in this oil is thin layer determined by chromatography [57]. Other scientific studies [58], Y. igde Pericarpine oil contains 0.2-0.5% to 1% phospholipid by weight. confirmed. Of these, 5.8% by weight is lecithin. skin's lipid barrier sterols that strengthen it, protect it from harmful substances originating from the teeth and pass through the epidermis. reduces excessive water loss, thereby increasing skin elasticity and firmness [59], [60]. y. The presence of small amounts (less than 1% by weight) of liposomes in lard proven, the active ingredients as well as skin tightening and skin It allowed it to bind with ceramides that smooth it [61].
Y. igde yaginda bulunan yag asitlerinin cilt için önemi Y. igde yaginda bulunan linoleik asit ciltte Önemli bir rol oynar. Kuru ciltte epidermisin lipid bariyerini güçlendirir ve transepidermal su kaybina karsi korur. The importance of fatty acids in lard oil for the skin Linoleic acid found in larch oil plays an important role in the skin. on dry skin It strengthens the lipid barrier of the epidermis and protects against transepidermal water loss.
Ek olarak, Linoliek asit (LA) cilt metabolizmasini düzenler [6], [17], [18], [52], olan kisilerde sebumda linoleik asit içeriginde bir azalma oldugu kaydedilinistir. In addition, Linoliic acid (LA) regulates skin metabolism [6], [17], [18], [52], It has been noted that there is a decrease in the content of linoleic acid in sebum in people with diabetes mellitus.
Sonuç olarak siyah nokta ve lekeler olusur. Yagli ve problemli cildin bakiminda kullanilan linoleik asit, yag bezlerinin fonksiyonlarini uyarabilir, gözeneklerin blokajini kaldirabilir ve siyah nokta sayisini sinirlayabilir. LA, hücreler arasi maddenin üretiminde de kullanilir [6], [53], [56]. Y. igde yaginda bulunan gamma- 25418.101 linolenik asit (GLA), delta-6-desatüraz enzimi ile linoleik asitten sentezlenir. Alfa- linolenik asitle (ALA) birlikte GLA, insan hücrelerinin hücre zarlarinin veya mitokondriyal zarlarinin bir bilesenidir [6], [10], [52], [56]. GLA ve ALA ayrica normal beyin içi ve hücreler arasi tasinimdan da sorumludur (beyni olusturan nöronal agdaki uyaranlarin aktarilmasi dahil) [6], [10], [54], [63]. Doymamis yag asitlerinin, özellikle omega-3 grubundaki (baslica EPA ve DHA), neoplastik tümörlerin gelismesinin yani sira, neoplastik doku ve daha sonra metastazi gelisimini engelledigi varsayilmaktadir [64]. Ayni zamanda, bu asitlerin, zararli bir UV radyasyonunun neden oldugu iltihap sonrasi maddeleri azaltabildigi de kanitlanmistir. Bu bilesikler günes yaniklarinin etkilerini azaltir, epiderinisin hasarli lipit bariyerinin rejeneratif süreçlerini hizlandirir ve tahrisi azaltir [48], [49], omega-3 (alfa-linolenik asitler) transepidermal su kaybini azaltir ve cildin hidrasyon seviyesini yükseltir [53], [55], [56]. Doymamis FA, cildin ve proteinlerin bariyer lipitlerinin sentezini uyaran reseptörlerin bir bölümünü uyarir [54], [55], Kozmetik ürünlerinde Y. igde yagi Y. igde yagi kozmetik endüstrisinde özellikle olgun ciltler için yapilan formüllerde kullanilir [15], [54]. Yaslanma karsiti ve kirisiklik karsiti ürünlerde en fazla ayrica, sarkmis ciltteki sertlesmis tondaki kirisikliklari azaltir [54]. Y. igde yagi kuru, tahris olmus (örnegin güneslendikten sonra), pürüzlü, pullanan ve kasintili cildin bakimi için de uygundur [40], [52]. Donmalarin ve Cilt hasarinin tedavisinde maruz kalmadan kaynaklanan durumlarda yardimci ürün olarak kullanilir. Örnegin epilasyon gibi kozmetik islemlerden sonra yatistirici bir ajan olarak kullanilir. As a result, blackheads and spots occur. In the care of oily and problematic skin The linoleic acid used can stimulate the functions of the sebaceous glands, It can unblock it and limit the number of blackheads. LA, intercellular It is also used in the production of the substance [6], [53], [56]. Y. gamma- 25418.101 Linolenic acid (GLA) is synthesized from linoleic acid by the enzyme delta-6-desaturase. Alpha- GLA, together with linolenic acid (ALA), is an important component of the cell membranes of human cells or It is a component of mitochondrial membranes [6], [10], [52], [56]. GLA and ALA also It is also responsible for normal intra-cerebral and intercellular transport (forming the brain). including the transmission of stimuli in the neuronal network) [6], [10], [54], [63]. unsaturated fat acids, especially in the omega-3 group (mainly EPA and DHA), neoplastic development of tumors, as well as neoplastic tissue and later metastasis It is assumed to inhibit its development [64]. At the same time, these acids are a harmful It can also reduce post-inflammatory substances caused by UV radiation. has been proven. These compounds reduce the effects of sunburns, accelerates the regenerative processes of the damaged lipid barrier and reduces irritation [48], [49], omega-3 (alpha-linolenic acids) reduce transepidermal water loss and increases hydration level [53], [55], [56]. Unsaturated FA, skin and proteins stimulates a portion of receptors that stimulate the synthesis of barrier lipids [54], [55], Y. igde oil in cosmetic products Y. lard oil is used in the cosmetic industry, especially in formulas made for mature skin. used [15], [54]. In anti-aging and anti-wrinkle products, the most it also reduces wrinkles in sagging skin and firmed tone [54]. Y. lard oil dry, irritated (for example, after sunbathing), rough, flaking and itchy it is also suitable for skin care [40], [52]. Treatment of frostbite and skin damage It is used as an auxiliary product in cases caused by exposure. For example It is used as a soothing agent after cosmetic procedures such as hair removal.
Sampuanlarda, saç kremlerinde veya ölmüs veya kalici dalga isleminden sonra kullanilan preparatlarda bulunmasi, hasar görmüs saçlarin yenilenmesini destekler, elastikiyetini geri kazandirir ve pürüzsüzlügü saglar. Yüksek doymamis yag asitleri 25418.101 içerigi [45], [52] ve buna bagli olarak Y. igde yaginin kozmetikte kapsül seklinde kullanilmasi önerilmektedir [46], [65]. In shampoos, conditioners or after dead or permanent wave treatment its presence in the preparations used supports the regeneration of damaged hair, restores its elasticity and provides smoothness. High unsaturated fatty acids 25418.101 content [45], [52] and accordingly Y. lard oil in the form of capsules in cosmetics. It is recommended to use [46], [65].
Teknikte bilinen uygulamalardan EP3413979 sayili Avrupa patent basvurusu dokümaninda, farkli boyutlarda damlaciklardan olusan bir karisim içerisinde yag faza sahip olan, su içerisinde yag (oil-in-water) emülsiyonlarindan bahsedilmektedir. Burada açiklanan emülsiyonlarin kozmetik kullanima yönelik oldugu ifade edilmektedir. Bulus içerisinde tercihen yabani igde (Seabuckthorn, Hippophae Rhamnoides) yaginin da yer aldigi bir gruptan seçilen bilesenlerin olabilecegi ifade edilmektedir. Ayrica, doymamis yag asitlerinin olabilecegi ve bunun linoleik asit ve y-linolenik asiti de içeren bir gruptan olabilecegi ifade edilmektedir. Bu bulusta homojen büyüklükte degil; farkli boyutlardaki droplar elde edilmistir. Yani iki sivi fazin bir konsantre kolloidal faza ayrilmasini esas alan, süspansiyon halinde polimer damlaciklarinin üretilmesi için kimyasal bir yöntem gelistirilmistir. basvurusu dokümaninda, bitki ekstraktlari içeren topikal kisisel bakim formülasyonlarindan bahsedilmektedir. Bulus kapsaminda kullanilabilecek bitkiler arasinda yabani igde (Hippophae Rhamnoides) de yer almaktadir. Bitki ekstraktlari ile ilave bilesenlerin deri gibi bir hedef bölgeye ulasimi için enkapsüle edilebilmesinden bahsedilmektedir. Burada kullanilabilecek bilesenler arasinda linoleik asit ve linolenik asit de yer almaktadir. European patent application no. EP3413979 from applications known in the art oil in a mixture of droplets of different sizes. oil-in-water emulsions is mentioned. The emulsions described herein are intended for cosmetic use. is expressed. In the invention, preferably wild igde (Seabuckthorn, Components selected from a group including Hippophae Rhamnoides) oil is stated to be possible. In addition, there may be unsaturated fatty acids and It is stated that it may be from a group that also includes linoleic acid and y-linolenic acid. is being done. In this invention, it is not of homogeneous size; drops of different sizes has been obtained. That is, based on the separation of two liquid phases into a concentrated colloidal phase, a chemical method for producing polymer droplets in suspension developed. topical personal care containing plant extracts formulations are mentioned. Plants that can be used within the scope of the invention Among them, wild igloo (Hippophae Rhamnoides) is also included. plant extracts encapsulates for delivery of additional components to a target area such as the skin. can be mentioned. Among the components that can be used here It also contains linoleic acid and linolenic acid.
Teknikte bilinen uygulamalardan FR2943255 sayili Fransiz patent basvurusu dokümaninda, Yabani igdenin (Hi'ppophae Rhamnoides) lipofilik ekstraktinin, menapozla alakali hormonal dengesizlikler sonucu olusan deri rahatsizliklarin tedavisi için üretilen bir kompozisyonda kullanilmasindan bahsedilmektedir. Bulus kapsaminda, ekstraktin, süperkritik C02 ekstraksiyon teknolojisi ile elde edildigi ifade edilmektedir. 25418.101 Teknikte bilinen uygulamalardan CN107137319 sayili Çin patent basvurusu dokümaninda, nano-yumusak-hassas bir detoksifiye edici kremden bahsedilmektedir. Bu krem içeriginde yabani igde (Hippophae Rhamnoides) yer aldigi belirtilmektedir. Bulus konusu kozmetik ürünü olan kremin üretim yöntemi iki temel adim içerrnekte olup, bunlardan birincisi, içerisinde yabani igde (Hzppophae Rhamnoides) ekstraktinin da bulundugu bilesenlerin karistirilmasi ve ikinci adim, bu karisimin lipozom teknolojisinin kullanilmasiyla lipozomlarda enkapsüle edilmesidir. French patent application no. FR2943255 from applications known in the art In the document, the lipophilic extract of wild igdenine (Hi'ppophae Rhamnoides), skin disorders caused by hormonal imbalances related to menopause It is mentioned that it is used in a composition produced for the treatment of Meet In this context, the extract is obtained by supercritical CO2 extraction technology. is expressed. 25418.101 Chinese patent application no. CN107137319 from applications known in the art from a nano-soft-delicate detoxifying cream is mentioned. This cream contains wild igloo (Hippophae Rhamnoides). received is indicated. The production method of the cream, which is the subject of the invention, is the cosmetic product. It consists of two basic steps, the first of which is the (Hzppophae Rhamnoides) extract, mixing the components and The second step is to produce this mixture in liposomes using liposome technology. is encapsulation.
Teknikte bilinen uygulamalardan TR 2017/ 15945 sayili Türk patent basvurusunda, bir pisik önleme ve tedavi kremi üretim yönteminden bahsedilmektedir. Bu bulus üretiminde ve içerdigi formül sayesinde, herhangi bir yan etkiye neden olmadan, cildi canlandirarak, hücreleri yenilemesi ile pisiklerin hem önlenmesinde hem de tedavi edilmesinde kullanilabilen bir pisik önleme ve tedavi kreminin üretim yöntemi ile ilgilidir. In the Turkish patent application numbered TR 2017/15945, one of the applications known in the art, A method of producing a rash prevention and treatment cream is mentioned. This invention Thanks to its production and the formula it contains, without causing any side effects, by rejuvenating the skin and renewing the cells, both in the prevention and manufacture of a rash prevention and treatment cream that can be used to treat relates to method.
Bulusun Kisa Açiklamasi Bulusun amaci, lipozomal teknoloji kullanarak enkapsülasyon metoduyla elde edilen Yabani Igde (Hippophae Rhamnofdes) ekstresinin yenileyici etkisi nedeniyle kisisel bakim ürünleri formülasyonlarinda kullanilmasidir. Brief Description of the Invention The aim of the invention is to obtain by encapsulation method using liposomal technology. Due to the regenerative effect of Wild Igde (Hippophae Rhamnofdes) extract It is used in personal care product formulations.
Bulusun Ayrintili Açiklamasi Bu bulusun amacina ulasmak için gerçeklestirilen “Enkapsüle Edilmis Yabani Igde (Hippophae Rhamnoides) Ekstresi Içeren Bir Kisisel Bakim Ürünü F ormülasyonu ve Bunun Üretim Yöntemi” ekli sekillerde gösterilmis olup; bu sekillerden: Sekill- Yabani yag ekstresinin enkapsülasyonu sonrasinda elde edilen karisim içerisinde partikül boyutunun (size), yogunluga bagli degisiminin grafiksel gösterimidir. 25418.101 Yabani igde extresinden hazirlanmis formülasyonun deri hücresi üzerinde doza bagli olarak gösterildigi yüzdesel canlilik grafigidir. gösterimidir. Üretim asamalarinin sematik gösterimidir. Detailed Description of the Invention To achieve the purpose of this invention, the “Encapsulated Wild A Personal Care Product Containing Igde (Hippophae Rhamnoides) Extract Its Formulation and Its Production Method” are shown in the attached figures; This from the figures: Sekill- Obtained after encapsulation of wild oil extract The particle size (size) in the mixture depends on the density. graphical representation of the change. 25418.101 Skin cell of the formulation prepared from wild berry extract It is the percentile vitality graph on which it is shown depending on the dose. is the display. It is a schematic representation of the production stages.
Enkapsülasyon metodu ile unilamellar vezikül elde edilmesinin sematik anlatlmidir. Obtaining unilamellar vesicle by encapsulation method sematically explained.
Sekillerdeki parçalar numaralandirllmls olup karsiliklari asagida verilmistir UVWEAcs. The parts in the figures are numbered and their equivalents are given below. UVWEAcs.
Yüksek Basinç Girisi- Pi (High Pressui'e [niet-P 1) Düsük Basinç Çikisi-Pz (Low Pressure Outlet-Pz) Yüksek Parçalama Bölgesi (Hiû= h Shear Zone) Yüksek Enerji Çarpisma Bölgesi (High Energy Impact Zone) Multilamellar lipozomlar (pre-emulsion) + Aktifler(Mu1tilamellar liposomes + Actives) Enkapsüle edilmis aktifleri içeren unilamellar veziküller (Unilamellar vesicles With encapsulated actives) Mikrofludizer islemci (Micrûfluidizer Processing) Yag Fazi Su Pazi Centellin Fazi Aktif Faz Emülsiyon Lipozomlu Yabani Igde Fazi Bulus, enkapsülasyon yöntemiyle elde edilen Yabani igde (Hippophae rhamnoides) ekstresi ile hazirlanan, yenileyici kisisel bakim ürünleri formülasyonlarinln gelistirilmesi ile ilgilidir. Bulus kapsaminda, lipofilik özellik tasiyan a-tocopherol ve b-carotene anti-oksidan yapidaki moleküllerden de faydalanmak üzere, Y. igde 25418.101 yagini lipozomal teknoloji ile enkapsüle edilerek emülsiyon (E) formundaki formülasyonlarda kullanilmasi ele alinmaktadir. High Pressure Input - Pi (High Pressui'e [niet-P 1) Low Pressure Outlet-Pz (Low Pressure Outlet-Pz) High Shear Zone (Hiû= h Shear Zone) High Energy Impact Zone Multilamellar liposomes (pre-emulsion) + Actives (Mu1tilamellar) liposomes + Actives) unilamellar vesicles containing encapsulated actives (Unilamellar vesicles With encapsulated actives) Microfluidizer Processing Fat Phase Water Chard Centellin Phase Active Phase Emulsion Wild Igde Phase with Liposome Invention, Wild igdem (Hippophae rhamnoides) obtained by encapsulation method Regenerative personal care product formulations prepared with extract relates to development. Within the scope of the invention, a-tocopherol with lipophilic properties and b-carotene, in order to benefit from molecules with antioxidant structure, Y. igde 25418.101 oil in emulsion (E) form by encapsulating with liposomal technology. its use in formulations is discussed.
Lipozomlar son yillarda tibbin pek çok uygulama alaninda ilgi odagi haline gelmistir. Lipozomlarin akiskanligi, geçirgenligi ve moleküler organizasyonu gibi özellikleri üzerine yogunlasmis olan fizikokimyasal çalismalar, dogal membranlarin yapisal elementi olarak çift katli lipit tabakalarinin önemini ortaya koymaktadir. Hücre biyolojisinde lipozom-hücre etkilesimleri, füzyon ve adhezyon gibi fizyolojik olaylara bir model teskil etmektedir. Buna ek olarak, hücre-hücre füzyonunu gelistirmek, membranlarin fosfolipit ve kolesterol içerigini degistirmek ve normal olarak suda çözünebilen, fakat hücre içine geçisi zor moleküllerin transferinde kullanilabilmektedir. Lipozomlar katmanli fosfolipitlerin bilesimiyle meydana gelen çok küçük (nanometre boyutunda) sulu faz içeren yapilardir. Liposomes have become the focus of attention in many medical applications in recent years. has arrived. such as the fluidity, permeability and molecular organization of liposomes. Physicochemical studies focused on the properties of natural It reveals the importance of lipid bilayers as the structural element of membranes. puts it. Liposome-cell interactions, fusion and adhesion in cell biology It provides a model for physiological events such as In addition, cell-cell improve the fusion of membranes, change the phospholipid and cholesterol content of the membranes and molecules that are normally water-soluble but difficult to pass into the cell. can be used for transfer. Liposomes are composed of layered phospholipids. They are very small (nanometer-sized) structures containing aqueous phase.
Lipozomlar, temel olarak aktif maddelerin etkinligini arttiracak ve istenmeyen toksik özelliklerini azaltacak sekilde, çok seçici olarak maddelerin tasinmasinda kullanilmaktadir. Diger durumlarda, lipozomlar etkinin uzatilmasinda, adsorbsiyonun gelistirilmesinde veya basitçe aktif maddelerin stabilize edilmesinde kullanilmaktadir. Boyutlari ve fizikokimyasal özellikleri, bu yapilarin kapsüllenmis ürünü serbest birakarak doku içine degisik yollarla penetrasyon ve difüzyonuna yol açmaktadir. Hücre biyolojisinde lipozom-hücre etkilesimleri, füzyon ve adhezyon gibi fizyolojik olaylara bir model teskil etmektedir. Buna ek olarak, hücre-hücre füzyonunu gelistirmek, membranlarin fosfolipit ve kolesterol içerigini degistirmek ve normal olarak suda çözünebilen, fakat hücre içine geçisi zor moleküllerin transferinde kullanilabilmektedir. Liposomes will basically increase the efficacy of the active substances and remove unwanted in the transport of substances very selectively, reducing their toxic properties is used. In other cases, liposomes can prolong the effect, in improving adsorption or simply stabilizing active substances is used. Their size and physicochemical properties indicate that these structures are encapsulated. releasing the product into the tissue, causing its penetration and diffusion into the tissue in different ways. opens. Liposome-cell interactions, fusion and adhesion in cell biology It provides a model for physiological events such as In addition, cell-cell improve the fusion of membranes, change the phospholipid and cholesterol content of the membranes and molecules that are normally water-soluble but difficult to pass into the cell. can be used for transfer.
Fosfolipitler, lipozomlarin ve hücre zarinin yapitaslaridir. Lipitler genellikle hidrofob ve apolar bir yapiya sahiptirler. Bu nedenle su ile karismazlar. Fakat, fosfolipitlerin fosfat grubu hidrofil ve polar yapiya sahip oldugundan, bunlar suyla karistirilabilmektedir. Lipozomun yapisi temelde hücre zari yapisi ile benzerlik göstermektedir. Lipozomlar hem hidrofilik polar hem de hidrofob apolar bosluklar içermektedir. Bu sayede suda çözünebilen maddeleri polar bosluklarinda, yagda 25418.101 çözünebilen maddeleri ise hidrofobik bosluklarinda kapsülleyerek bunlar için bir tasiyici vazifesi görebilmektedirler. Phospholipids are the building blocks of liposomes and cell membranes. Lipids are usually They are hydrophobic and nonpolar. Therefore, they do not mix with water. But, Since the phosphate group of phospholipids has a hydrophilic and polar structure, they can be mixed. The structure of the liposome is basically similar to the cell membrane structure. shows. Liposomes contain both hydrophilic polar and hydrophobic apolar spaces. contains. In this way, water-soluble substances in polar spaces, oil 25418.101 by encapsulating soluble substances in their hydrophobic spaces, they can act as a carrier.
Bulus kapsaminda olusturulan kozmetik ürün forrnülasyonlari, içerdigi kozmetik aktif içerigi ve üstün teknoloji ile hazirlanan formülasyonu sayesinde hücre yenilenmesini saglamaktadir. Kozmetik aktif içerigi olan Yabani igde ekstresi, lipozomal teknoloji kullanarak enkapsüle edilerek hazirlanmaktadir. Yabani igdenin (Hippophae rhamnoi'des) yani sira, bulus kapsaminda gelistirilen formülde bulunan; Hyaluronik asit, Helianthus Annuus (Sunilower) Seed Oil, Centella Asiatica Extract, Glycine Soja (Soybean) Protein dogal içerikleri sayesinde hücrelerin yenilenmesini artirilirken, Tocopherol Acetate ve Superoxide Dismutase sayesinde cilde zarar veren oksijen radikallerinden korunma saglanmaktadir. The cosmetic product formulations created within the scope of the invention Thanks to its active content and formulation prepared with superior technology, the cell provides renewal. Wild igdem extract, which is a cosmetic active ingredient, It is prepared by encapsulation using liposomal technology. Wild In addition to igden (Hippophae rhamnoi'des), the formula developed within the scope of the invention found; Hyaluronic acid, Helianthus Annuus (Sunilower) Seed Oil, Centella Thanks to its natural ingredients of Asiatica Extract, Glycine Soja (Soybean) Protein While increasing the regeneration of cells, Tocopherol Acetate and Superoxide Dismutase It provides protection from oxygen radicals that damage the skin.
Bitkisel yaglar, genellikle bitkilerin tohumlari, meyveleri gibi çesitli kisimlarindan mekanik olarak ekstraksiyon veya soguk presleme yoluyla elde edilir. Kimyasal olarak bu yaglar, ester-bagli gliserol bilesikleri ve uzun alifatik zincir hidrokarbonlu (min. Cl4: 0) daha yüksek yag asitleridir. Bitkisel yaglar, doyma yüzdelerine bagli olarak çesitli özelliklere sahiptir. Bulus kapsaminda, iyi karakterize edilmis Yabani igde meyve ve tohumlarindan elde edilen Y. igde yagi kullanilmaktadir. Yabani igde bitkisi, çok sayida aktif bilesene sahip olmasi nedeniyle kozmetik endüstrisinde ve tip alaninda basariyla kullanilmaktadir. Y. igde yaginda bulunan degerli içerikler insan vücudunun düzgün çalismasinda önemli bir rol oynar ve cilde saglikli bir görünüm kazandirir, Içerdigi yag asitlerinin dengeli miktari, vitaminlerin türleri, miktari, kuru veya hizli yaslanan kozmetik ürünlerde Cilt bakimi için kullanimini açiklamaktadir. Palmito-oleik asit (omega-7) ve y-linolenik asit (omega-6) gibi doymamis yag asitleri, cildin yenilenmesini ve onarilmasini saglar. Y. igde yagi kan dolasimini hizlandirir, cildin oksij enlenmesini kolaylastirir, fazla toksinleri vücuttan uzaklastirir ve epidermisten kolayca nüfuz eder. Pek çok özelligi nedeniyle Y. igde yagi saglik ve güzellik ürünlerinde kullanilan degerli bir katkidir. 25418.101 Bulus konusu, kozmetik sektöründe anti-aging amaciyla kullanilan kisisel bakim ürünü formülasyonunun üretim yöntemi; Centellin 40 oC7de Çözündükten sonra su fazina (SF) ilave edilmesi, Yag fazinin (YF), su fazina (SF) eklenerek 80 0C sicaklikta emülsiyon (E) (Oil-in-Water) olusturulmasi, Emülsiyonun (E) karistirilmasi ve sogutulmasi, Emülsiyonun (E) 60 0C sicakliga sogutulmasinin ardindan homojenizatör ile homojen hale getirilmesi ve karistirma hizinin düsürülmesi, Emülsiyon (E) sicakligi, 30 0C sicakliga ulastiginda aktif fazda (AF) bulunan içeriklerin emülsiyona (E) ilave edilmesi, Emülsiyonun (E) tekrar homojenize edilmesi ve homojenizatörün kapatilmasi, Lipozomlu Yabani lgde yagi fazinin emülsiyona (E) ilave edilmesi ve homojenize karisim saglanincaya kadar karistirmanm sürdürülmesi, Emülsiyon (E) pH'inin 5,5 - 6,5 olacak sekilde ayarlanmasi, Kisisel bakim formülasyonu olarak kullanilan emülsiyonun (E) elde edilmesi adimlarini içermektedir. Vegetable oils are generally derived from various parts of plants such as seeds and fruits. obtained by mechanical extraction or cold pressing. Chemical These oils contain ester-linked glycerol compounds and long aliphatic chain hydrocarbons. (min. Cl4: 0) are higher fatty acids. Vegetable oils, depending on their saturation percentage has various features. Within the scope of the invention, well-characterized Olive oil obtained from igneous fruits and seeds is used. Wild The igneous plant is used in cosmetic products due to its many active ingredients. It is used successfully in the industry and in the field of medicine. found in Y. igde oil valuable ingredients play an important role in the proper functioning of the human body and It gives a healthy appearance, Balanced amount of fatty acids it contains, types, amounts of vitamins, in dry or fast-aging cosmetic products explains its use for maintenance. Palmito-oleic acid (omega-7) and y-linolenic unsaturated fatty acids, such as acid (omega-6), help regenerate and repair the skin. it provides. Y. lard oil accelerates blood circulation, facilitates oxygenation of the skin, It removes excess toxins from the body and easily penetrates through the epidermis. Most Due to its feature, olive oil is a valuable product used in health and beauty products. it is a contribution. 25418.101 The subject of the invention is the personal care product used for anti-aging in the cosmetic industry. production method of the formulation of the product; Centellin is added to the water phase (SF) after dissolving at 40 oC, Emulsion (E) at 80 0C by adding the oil phase (YF) to the water phase (SF) (Oil-in-Water) creation, Mixing and cooling of the emulsion (E), After the emulsion (E) is cooled to 60 0C, the homogenizer homogenizing and reducing the mixing speed, When the emulsion (E) temperature reaches 30 0C, it is in the active phase (AF) adding the found ingredients to the emulsion (E), Re-homogenizing the emulsion (E) and closing, The addition of the liposome Wild Ig oil phase to the emulsion (E) and Continuing mixing until homogenized mixture is obtained, Adjusting the emulsion (E) pH to be 5.5 - 6.5, The emulsion (E) used as a personal care formulation is obtained. includes steps.
Fazlarin Olusturulmasi 1. Yag Fazinin (YF) Olusturulmasi Yag fazinda (YF) bulunan içerikler; agirlikça, % 0,001-0,01 Tocopherol; % 0,1 - Lecithin; % 0,2 - 0,7 Palmitic acid; % 1 - 5 Caprylic/capric triglyceridleri sirasiyla tartilip cam behere alinmasi ve 80 °C sicakliga isitilmasi 2. Su Fazinin (SF) Olusturulmasi Su fazinda (SF) bulunan içerikler; agirlikça, % 0,3 - 0,7 Caffeine; % 0,05 - 0,3 - 1,0 Hyaluronic asit; % 0,l - 1,0 Allantoin sirasiyla cam behere alinmasi. Creating Phases 1. Formation of Oil Phase (YF) The ingredients in the oil phase (YF); by weight, 0.001-0.01% Tocopherol; 0.1% - Lecithin; 0.2 - 0.7% Palmitic acid; 1 - 5% Caprylic/capric triglycerides, respectively weighed and poured into a glass beaker and heated to 80 °C. 2. Formation of the Water Phase (SF) Ingredients in the water phase (SF); by weight, 0.3 - 0.7% Caffeine; 0.05 - 0.3% - 1.0 Hyaluronic acid; 0,1 - 1,0% Allantoin, respectively, in a glass beaker.
Olusturulan karisimin pH:5,5 degerine ayarlanmasi ve 80 0C sicakliga isitilmasi 25418.101 3. Centellin Fazinin (CF) Olusturulmasi Centellin (Centeli'a asiatica) bitkisinin ekstrakti agirlikça, % 0,2 - 0,7 propylene glyeol içerisinde 40 0C sicaklikta cam beherde çözünmesi 4. Aktif Fazinin (AF) Olusturulmasi Aktif fazda (AF) bulunan içerikler, agirlikça, % 0,4 2 1,5 Sorbitan caprylate; % 0,01 dismutase; % 0,4 - 1,5 Tocopherol Acetate . Lipozomlu Yabani Igde Fazinin (LYIF) olusturulmasi Lipozom hazirlama prosesi: 100 g°lik Lipozom Çözeltisi hazirlamak için; 2 gram Lecithin tartilmakta ve 88 gram su içerisinde homojenizatör kullanilarak 20.000 rpin"de karistirarak çözünmesi saglanmaktadir. Elde edilen bu sulu Lipozom çözeltisine 10 gram Yabani Igde Yagi ilave ederek 5-10 dakika daha homojenizatör kullanilarak 20.000 rpm'de karistirilmaktadir. Elde edilen karisim 20.000 psiide microfludize Cihazi kullanilarak, 3 defa (passes) geçirilerek homojen hale getirilmektedir. Adjusting the created mixture to pH:5,5 and heating it to 80 0C 25418.101 3. Creation of Centellin Phase (CF) Extract of Centellin (Centeli'a asiatica) plant 0.2% - 0.7% propylene by weight Dissolution in glieol in a glass beaker at 40 0C 4. Establishment of Active Phase (AF) Ingredients in active phase (AF), by weight, 0.4% 2 1.5 Sorbitan caprylate; 0.01% dismutase; 0.4 - 1.5% Tocopherol Acetate . Formation of Liposome Wild Igland Phase (LYIF) Liposome preparation process: To prepare 100 g Liposome Solution; 2 grams of Lecithin is weighed and 88 by mixing at 20,000 rpm using a homogenizer in grams of water. dissolution is provided. 10 grams of this obtained aqueous Liposome solution By adding Wild Igde Oil and using a homogenizer for another 5-10 minutes, 20.000 It is mixed at rpm. The resulting mixture is 20.000 psiide microfludizer. It is made homogeneous by passing it 3 times (passes).
Lipozomlu Yabani Igde (seabuekthorn- SB) Agirlikça % içerigi Solüsyonu LECITHIN 2 Bulus kapsaminda kullanilan Yabani i gde yagi, süper kritik ekstraksiyon metoduyla elde edilmektedir ve inorganik tuzlar içermernektedir. Mikroakiskaniastirici (Microtludizer) sisteminde, yabani igde ekstresi %0,6°lik lesitin (lecithin) solüsyonu ile enkapsüle edilmektedir. Bu ekstrenin enkapsülasyon islemi yapilmadan önce ve enkapsülasyon yapilmasi sonrasinda moleküllerinin homojen 25418.101 olup olmadigina bakilmaktadir. Mikroakiskanlastirici cihaziyla 3 kez chamberdan geçirilerek elde edilen ekstrenin homojenite dagilimi gözlemlenmistir (Sekil 1). Wild Igde with Liposome (seabuekthorn- SB) % content by weight solution LECITHIN 2 Wild mulberry oil used in the scope of the invention was obtained by supercritical extraction method. is obtained and does not contain inorganic salts. Microfluidics In the (Microtludizer) system, 0.6% lecithin (lecithin) in the wild igda extract encapsulated with solution. The encapsulation process of this extract homogeneous molecules before and after encapsulation. 25418.101 It is being checked whether or not. Out of the chamber 3 times with the microfluidizer device The homogeneity distribution of the extracted extract was observed (Figure 1).
Buna göre enkapsüle edilmis Y. igde içeren ekstrede bulunan moleküllerin %931ü 314 nm boyutundadir. Bu çalismada homojen Y. igde moleküllerinin elde edildigi görülmektedir. Accordingly, 931% of the molecules in the extract containing encapsulated Y. igde It is 314 nm in size. In this study, homogeneous Y. igde molecules were obtained. is seen.
Bulus kapsaminda, Y. igde yaginin fosfolipid ile enkapsüle edilmesi için Mikrofluidizer islemci (MP) (mikroakiskanlastirici) sistemi kullanilmaktadir. Within the scope of the invention, for encapsulation of Y. lard oil with phospholipid. Microfluidizer processor (MP) (microfluidizer) system is used.
Microtludizer likit sistemlerin çalisma prensibi, likit emulsifiye sistemlerin veya likit içinde dagilmis olan kati maddenin birbiriyle güçlü sekilde çarpistirilmasi temeline dayanir. Bu islem interaction Chamber içinde yüksek eneiji yogunlugunda meydana gelir. MicroIluidizer: Parçacik büyüklügü küçültme, Hücre parçalama, Emülsiyonlar (E), Reaksiyon teknolojisi (diger bir deyisle, Microtluidics Reaction Technology (MRT)) islemlerinde kullanilmaktadir. Tüm ürün, tek tip olarak, sürekli olarak ve ayni islem kosullarinda elde edilir ve su sonuçlarla tekrarlanabilir bir sekilde çalisir: Küçük partikül veya damlacik büyüklügü (genellikle mikron alti), Düzgün partikül veya damlacik ebadi (küçük poli dagilma indeksi), Tamamen ölçeklenebilir süreç ve Islem sürekliligi. “Z-tip Chamber” seklinde bir mikroakiskanlastiricinin sematik gösterimi Sekil 3 içerisinde gösterilmektedir. The working principle of Microtludizer liquid systems, liquid emulsifying systems or strong collision of solid matter dispersed in the liquid with each other is based on. This process is performed in the interaction Chamber with high energy density. it occurs. MicroIluidizer: Particle size reduction, Cell fragmentation, Emulsions (E), Reaction technology (aka Microtluidics Reaction It is used in Technology (MRT)) operations. The whole product, as one type, obtained continuously and under the same processing conditions and can be reproduced with such results It works in one way: Small particle or droplet size (usually microns) six), Uniform particle or droplet size (small poly dispersion index), Completely scalable process and Transaction continuity. A “Z-type Chamber” The schematic representation of the microfluidizer is shown in Figure 3.
Mikrotluidizer islemci (MP), malzemeyi çok küçük bir delikten geçmeye zorlayan büyük bir pompa görevi görür. Isletme basinçlari 3.4 MPa/ 500 psi civarinda baslar ve 275 MPa / 40.000 psi'ye kadar çikar. Proses basinci, istenen parçacik büyüklügü dagilimini elde etmek amaciyla farkli uygulamalara göre degisir. Mikrofluidizer islemcinin (MP), sivi sivi sistemi birbirine emülsiliye etmesi veya bir kati maddenin sivida dagilmasi ve ayrismasi için söz konusu kesme basinci, basincin etkisi ve kavitasyon olusturma kuvvetlerine baglidir. Bu islem interaction odacigmda yüksek enerji seviyelerinde gerçeklesir. Microtluidizer processor (MP), which forces the material to pass through a very small hole. acts as a great pump. Operating pressures start around 3.4 MPa/ 500 psi and up to 275 MPa / 40,000 psi. Process pressure, desired particle size varies according to different applications in order to obtain the distribution of Microfluidizer The processor (MP) emulsifies the liquid-liquid system together or a solid the said shear pressure, the effect of the pressure and the depends on the cavitation forces. This process is high in the interaction chamber. occurs at energy levels.
Formülasyonda söz konusu ekstre aktif kozmetik içerigi olarak aktif fazda (AF) kullanilmaktadir. Bu ekstrenin kullanilmasiyla olusturulan emülsiyon (E) 25418.101 formülüne deri hücresi üzerinde doza bagli olarak gösterildigi yüzdesel canlilik (vitality) testi ile analiz edilmistir. Canlilik testi; ISO EN 10993-5'e göre söz konusu krem için ATCC-CCL-81 VERO hücrelerinde ya saf (%100) veya hücre kültürü ortaminin seri seyreltilmelerinde bir sitotoksisite çalismasi gerçeklestirildi. kullanilmistir. Besiyeri olarak 10% Fetal Bovine Serum (Gibco Cat no #10500-64) + Antibiotic-Antimycotic (Gibco #15240-062) katilmis MEM sulandirmalarla hücre kültürü üzerine uygulandi. 37 °C° de %5 CO2”de 24 saat inkübe edildi. In the formulation, the extract in question is in the active phase (AF) as an active cosmetic ingredient. is used. Emulsion (E) created by using this extract 25418.101 the percentage of viability in which the formula is shown on the skin cell in a dose-dependent manner. (vitality) test was analyzed. vitality test; Promise according to ISO EN 10993-5 For the cream in question, ATCC-CCL-81 VERO cells were either pure (100%) or cellular A cytotoxicity study was performed on serial dilutions of culture medium. used. 10% Fetal Bovine Serum as medium (Gibco Cat no #10500-64) + Antibiotic-Antimycotic (Gibco #15240-062) with added MEM dilutions applied to cell culture. It was incubated for 24 hours at 37 °C and 5% CO2.
Hücrelere MTS/PMS solusyonu uygulandi. Inkübasyon sonunda olusan formazan kristalleri spektrofotometrede 490nm-630nm dalga boyunda ölçümleri yapildi. MTS/PMS solution was applied to the cells. Formazan formed at the end of incubation The crystals were measured in a spectrophotometer at a wavelength of 490nm-630nm.
Pozitif ve negatiflere göre sitotoksisite indeksleri hesaplanarak kremin sitotoksik etkisi test edildi. Sonuç olarak; hücre kültüründeki hücrelere toksik etki göstermemektedir. Ayrica test edilen kremin %0,05”lik konsantrasyonda hücre proliferasyonunu %136 oraninda artirdigi gözlemlenmistir. Cytotoxicity indexes were calculated according to the positive and negatives, and the cytotoxicity of the cream was calculated. effect was tested. In conclusion; toxic effect on cells in cell culture does not show. In addition, 0.05% concentration of the tested cream It was observed that it increased its proliferation by 136%.
Bulus kapsaminda, homojen bir dagilim gösteren lipozomlanmis Yabani igde yagi droplari; %93 ”ü homojen sekilde 314 nm boyutunda elde edilmistir. Bu sekilde elde edilen emülsiyon (E) formülün hücre yenilenmesini %136 oraninda artirdigi bulunmustur. Within the scope of the invention, liposomed wild buckthorn oil showing a homogeneous distribution drops; 93% of it was obtained homogeneously at 314 nm size. In this way you get emulsion (E) formula increased cell renewal by 136%. has been found.
Bulus gelistirilmesi sürecinde, elde edilen kozmetik ürünün mikrobiyolojik çalisilan mikrobiyolojik uygunluk testine göre 25 °C ve 40 OC`de Staphylococcus aureus, Pseudomonas aeruginosa, Candida albicans ya da Escherichia coli üremesine saptanmamistir. During the development of the invention, the microbiological analysis of the obtained cosmetic product Staphylococcus at 25 °C and 40 °C according to the microbiological compatibility test studied aureus, Pseudomonas aeruginosa, Candida albicans or Escherichia coli reproduction was not detected.
Claims (1)
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| TR2020/08828A TR202008828A2 (en) | 2020-06-08 | 2020-06-08 | METHOD OF OBTAINING HIPPOPHAE RHAMNOIDES EXTRACT ENCAPSULATED WITH LIPOSOMAL TECHNOLOGY FOR USE IN COSMETIC FORMULAS |
| PCT/TR2021/050547 WO2021251934A1 (en) | 2020-06-08 | 2021-06-07 | Method of obtaining sea buckthorn (hippophae rhamnoides) extract encapsulated with liposomal technology for use in cosmetic formulas |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| TR2020/08828A TR202008828A2 (en) | 2020-06-08 | 2020-06-08 | METHOD OF OBTAINING HIPPOPHAE RHAMNOIDES EXTRACT ENCAPSULATED WITH LIPOSOMAL TECHNOLOGY FOR USE IN COSMETIC FORMULAS |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TR202008828A2 true TR202008828A2 (en) | 2021-12-21 |
Family
ID=78846337
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TR2020/08828A TR202008828A2 (en) | 2020-06-08 | 2020-06-08 | METHOD OF OBTAINING HIPPOPHAE RHAMNOIDES EXTRACT ENCAPSULATED WITH LIPOSOMAL TECHNOLOGY FOR USE IN COSMETIC FORMULAS |
Country Status (2)
| Country | Link |
|---|---|
| TR (1) | TR202008828A2 (en) |
| WO (1) | WO2021251934A1 (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN114392058B (en) * | 2022-01-17 | 2022-12-06 | 贵州卡布婴童用品有限责任公司 | Nursing type dry and comfortable paper diaper |
| TR2022010281A2 (en) * | 2022-06-21 | 2022-07-21 | Umayana Arastirma Gelistirme Ve Ilac Sanayi Anonim Sirketi | AN ENCAPSULATED PHARMACEUTICAL COMPOSITION FOR THE RELIEF OF DRY MOUTH AND SYMPTOMS DUE TO SYSTEMIC DISEASES |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103584081A (en) * | 2013-07-31 | 2014-02-19 | 中央民族大学 | Preparation method of seabuckthorn oil microcapsule |
| CN105796460A (en) * | 2016-03-21 | 2016-07-27 | 浙江大学 | Seabuckthorn oil body lotion containing hydrolyzed pearl powder flexible nano liposome |
| CN108402465A (en) * | 2018-03-09 | 2018-08-17 | 北京素维生物科技有限公司 | A kind of micro-capsule compound powder and its preparation process containing peculiar smell oils |
-
2020
- 2020-06-08 TR TR2020/08828A patent/TR202008828A2/en unknown
-
2021
- 2021-06-07 WO PCT/TR2021/050547 patent/WO2021251934A1/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| WO2021251934A1 (en) | 2021-12-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR101584742B1 (en) | Cosmetic composition for improving skin-aging | |
| KR101511148B1 (en) | Cosmetic composition for reinforcing skin barrier containing Persicaria hydropiper L. extract, and the liposome for enhancing transdermal delivery of Persicaria hydropiper L. extract | |
| KR20040021593A (en) | Cosmetic preparation containing vitamin a | |
| RU2665946C2 (en) | Composition containing onion extract and liposomes | |
| KR101797285B1 (en) | Natural liposome, process for the preparation thereof, and cosmetic composition comprising the same | |
| KR101627051B1 (en) | Natural liposome comprising vitamin C, process for the preparation thereof, and cosmetic composition comprising the same | |
| US20110250239A1 (en) | Pharmaceutical and/or cosmetic composition for treating the skin | |
| TR202008828A2 (en) | METHOD OF OBTAINING HIPPOPHAE RHAMNOIDES EXTRACT ENCAPSULATED WITH LIPOSOMAL TECHNOLOGY FOR USE IN COSMETIC FORMULAS | |
| KR101498609B1 (en) | Manufacturing method of bodylotion using herb and bodylotion made by that manufacturing method | |
| KR20120086438A (en) | Cosmetic composition for slimming comprising Salicornia herbacea L. and Rosa rugosa THUNB extract | |
| KR20130025988A (en) | Liposome encapsulating herbal extracts and the method for preparing the same | |
| RU2475230C1 (en) | Therapeutic sunburn product | |
| KR20180088051A (en) | Compositions for decreasing sebum and improving acne comprising extracts of Pinus densiflora leaf, Artemisia annua and Citrus junos fruit | |
| WO2015049265A1 (en) | Oily composition containing an extract of daylily and uses thereof | |
| KR102118542B1 (en) | Nano liposome herbal complex extract composition having an effect of relieving itching, strengthening immunity and reducing eye fatigue and preparation method thereof | |
| KR101216151B1 (en) | The composition for cosmetics containing extracts of Lithospermum erythrorhizon and Angelica gigas Nakai | |
| KR100681703B1 (en) | Cosmetic composition for enhancing skin moisture, which contains a mixed extract of camphor ginseng, skirt mushroom and yellow white stabilized by nanoliposomes as an active ingredient | |
| KR20150008825A (en) | Cosmetic composition for reinforcing skin barrier containing isoquercitrin, and the liposome for enhancing transdermal delivery of isoquercitrin | |
| KR100858628B1 (en) | Cosmetic composition for skin stimulation alleviation comprising soruja extract stabilized with nano liposomes | |
| KR102246331B1 (en) | Biodegradable nano-particle containing pinus bungeana extract and preparation method thereof | |
| KR102194920B1 (en) | Extract of mixed herbs for improving acnes, and cosmetic composition comprising the same, and mask pack containing the same | |
| Majeed et al. | Development And Characterization Of Topical Phospholipid Formulations Containing Chromolaena Odorata Extract To Ameliorate Skin Ageing | |
| KR100807153B1 (en) | Cosmetic composition for preventing skin aging containing herbal extract mixture stabilized with nanoliposomes | |
| RU2241440C2 (en) | Cosmetic preparation for taking care of problematic skin and method for its obtaining | |
| WO2025101134A1 (en) | Tri-herbosome composition and method |